Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    Loans
    HomeNewsAurobindopharma

    Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More

    Jump to
    • Exit Aurobindo Pharma, advises Sudarshan Sukhani

      Exit Aurobindo Pharma, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends exiting Aurobindo Pharma.

    • Buy Sun Pharma, Aurobindo Pharma: Sudarshan Sukhani

      Buy Sun Pharma, Aurobindo Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Sun Pharma and Aurobindo Pharma and feels that pharma as a sector will do well.

    • Buy Aurobindo Pharma, BPCL: Meghana Malkan

      Buy Aurobindo Pharma, BPCL: Meghana Malkan

      Meghana Malkan of malkansview.com recommends buying Aurobindo Pharma and Bharat Petroleum Corporation.

    • Aurobindo Pharma may head higher: Sudarshan Sukhani

      Aurobindo Pharma may head higher: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com is of the view that Aurobindo Pharma may head higher.

    • Aurobindo Pharma, Biocon top picks: Naveen Kulkarni

      Aurobindo Pharma, Biocon top picks: Naveen Kulkarni

      Naveen Kulkarni, co-head, research at Phillip Capital is of the view that Aurobindo Pharma and Biocon are the top picks from the pharma space.

    • Aurobindo Pharma may test Rs 1400, says Ashish Chaturmohta

      Aurobindo Pharma may test Rs 1400, says Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Group is of the view that Aurobindo Pharma may test Rs 1400.

    • Prefer Infosys, TCS, Axis Bank, HDFC Bank: Gaurang Shah

      Prefer Infosys, TCS, Axis Bank, HDFC Bank: Gaurang Shah

      Gaurang Shah of Geojit BNP Paribas Financial Services is of the view that one may prefer Infosys, HCL Technologies and Tata Consultancy Services from IT space.

    • Buy Voltas, Hexaware; sell Aurobindo Pharma: Gaurav Bissa

      Buy Voltas, Hexaware; sell Aurobindo Pharma: Gaurav Bissa

      Gaurav Bissa of LKP Securities recommends buying Voltas and Hexaware Technologies and advises selling Aurobindo Pharma.

    • Short Aurobindo Pharma, says Gaurav Bissa

      Short Aurobindo Pharma, says Gaurav Bissa

      Gaurav Bissa of LKP Securities is of the view that one can short Aurobindo Pharma with a target of Rs 1250.

    • Buy Aurobindo Pharma 1250 Put, says Rahul Shah

      Buy Aurobindo Pharma 1250 Put, says Rahul Shah

      Rahul Shah of Motilal Oswal Securities suggests buying Aurobindo Pharma 1250 Put.

    • Sell Century Textiles and Industries: Pritesh Mehta

      Sell Century Textiles and Industries: Pritesh Mehta

      Pritesh Mehta of IIFL recommends selling Century Textiles and Industries and feels that Aurobindo Pharma may test Rs 1200.

    • Buy Aurobindo Pharma, Lupin: Vishal Malkan

      Buy Aurobindo Pharma, Lupin: Vishal Malkan

      Vishal Malkan of malkansview.com suggests buying Aurobindo Pharma and Lupin.

    • Modi@365: Best & worst performing stocks

      Modi@365: Best & worst performing stocks

      CNBC-TV18‘s Varinder Bansal gives a check on the best & worst performing stocks in this last one year of Modi government.

    • Glenmark, Dr Reddy's top picks: R Sreesankar

      Glenmark, Dr Reddy's top picks: R Sreesankar

      R Sreesankar, Head-Institutional Equities at Prabhudas Lilladher is of the view that Glenmark Pharma, Dr Reddy's Laboratories and Aurobindo Pharma are the top picks from the pharma space.

    • Aurobindo Pharma may test Rs 1480-1490: Rahul Mohindar

      Aurobindo Pharma may test Rs 1480-1490: Rahul Mohindar

      Rahul Mohindar of viratechindia.com feels that Aurobindo Pharma may test Rs 1480-1490 in the medium-term.

    • Hold Lupin, prefer Cadila, Aurobindo Pharma: Anand Tandon

      Hold Lupin, prefer Cadila, Aurobindo Pharma: Anand Tandon

      Market Expert, Anand Tandon is of the view that one may hold Lupin with long term view.

    • Enter Bajaj Auto between Rs 2140-2170: CK Narayan

      Enter Bajaj Auto between Rs 2140-2170: CK Narayan

      CK Narayan of Growth Avenues advises buying Bajaj Auto between Rs 2140-2170.

    • Aurobindo Pharma may test Rs 1430-1440: Ashish Chaturmohta

      Aurobindo Pharma may test Rs 1430-1440: Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Group is of the view that Aurobindo Pharma may test Rs 1,430-1,440 in next couple of trading sessions.

    • Go long in Aurobindo Pharma, Oracle Financial: Chaturmohta

      Go long in Aurobindo Pharma, Oracle Financial: Chaturmohta

      Ashish Chaturmohta of Fortune Equity Broker recommends going long in Aurobindo Pharma and Oracle Financial Services Software

    • Prefer Strides Arcolab, Sun Pharma: Deepak Shenoy

      Prefer Strides Arcolab, Sun Pharma: Deepak Shenoy

      Deepak Shenoy of Capital Mind is of the view that one may prefer Strides Arcolab and Sun Pharma.

    • Buy Aurobindo Pharma 1200 Put, says Rahul Shah

      Buy Aurobindo Pharma 1200 Put, says Rahul Shah

      According to Rahul Shah of Motilal Oswal, one may buy Aurobindo Pharma 1200 Put.

    • Sell Aurobindo Pharma, Tech Mahindra: Kunal Saraogi

      Sell Aurobindo Pharma, Tech Mahindra: Kunal Saraogi

      Kunal Saraogi of Equityrush recommends selling Aurobindo Pharma and Tech Mahindra.

    • Stay invested in Aurobindo Pharma: Sudarshan Sukhani

      Stay invested in Aurobindo Pharma: Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends staying invested in Aurobindo Pharma.

    • Buy Aurobindo Pharma, advises Sudarshan Sukhani

      Buy Aurobindo Pharma, advises Sudarshan Sukhani

      Sudarshan Sukhani of s2analytics.com recommends buying Aurobindo Pharma as the stock may test new highs.

    • Go long in Glenmark, Aurobindo Pharma: Ashish Chaturmohta

      Go long in Glenmark, Aurobindo Pharma: Ashish Chaturmohta

      Ashish Chaturmohta of Fortune Group recommends going long in Glenmark Pharma and Aurobindo Pharma.

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347